04P-0386
CP 1
Volume 1

Cover Letter

List of Exhibits

Exhibit 1 - Letter from Reliant to Abbott/Foumier re submission of 505(b)(2)

Exhibit 2 - Letter from Eugene M. Gelernter to Andrew M. Berdon

Exhibit 3 - Letter from Andrew M. Berdon to Eugene M. Gelemter

Exhibit 4 - Letters from Ian W. French, Cipher, to Abbott Laboratories

Exhibit 5 - CML Healthcare Subsidiary Cipher Pharmaceuticals Concludes Distribution and Supply Agreement for Fenofibrate (Cipher Press Release)

Exhibit 6 - Reliant Pharms. Inc. v. Abbott Laboratories & Laboratoires Foumier, No. C.A. 04-350 (D. Del.)

Exhibit 7 - Marion Merrell Dow:, Inc. v. Hoechst-Roussel Pharmaceuticals, Inc. No. 93-5074 (AET) 1994 WL
424207 (D.N.J.)

Exhibit 8 - Reliant Pharms. Inc. v. Abbott Laboratories & Laboratoires Foumier, No. C.A. 04-350 (D. Del.)

Exhibit 9 - Marion Merrell Dow, Inc. v. Hoechst-Roussel Pharmaceuticals, Inc. No. 93-5074 (AET) 1994 WL
424207 (D.N.J.)

Exhibit 10 - Andrx Fortamet Approved: Dosing Convenience Will Be Marketing Focus, FDC Reports, The Pink Sheet

Exhibit 11- Andrx Reports 2003 Fourth Quarter and Full Year Results, Business Wire 5